Saturday, December 3, 2022


Biotechnology News Magazine


Quotient Sciences Acquires Arcinova

The acquisition expands Quotient’s service portfolio and will enable the integration of drug substance, drug product and clinical testing capabilities all under one organization

Eli Lilly Completes Acquisition of Prevail Therapeutics

Eli Lilly notes the acquisition establishes a new modality for drug discovery and development at Lilly.